Technology

Global Health Exhibition to Showcase Unique Advances in AI-Enabled Diagnostics and Patient Care

Published

2 years ago

September 26, 2024

The event’s Digital Health Forum will reveal the world’s latest developments in artificial intelligence (AI) enabled diagnostic decision-making for an audience of over 100,000 delegatesThe transformative impact of AI, big data and machine learning on patient care will revolutionize the speed and accuracy of diagnosis across multiple therapeutic areas, according to the event’s expert panellistsDigital Health Forum will highlight unique examples of utilising AI algorithms and applications set to enhance patient outcomes in radiology as well as the use of augmented intelligence which can monitor patients in real-timeGlobal Health Exhibition (Malham, Riyadh, 21-23 October 2024) will bring 1,200 exhibiting companies to Saudi Arabia and is poised to become one of the world’s top three most-attended healthcare forumsEvent will host 500+ expert speakers across multiple healthcare disciplines highlighting frontier-pushing medical advancements alongside over 100 hours of accredited CME opportunities for medical professionals

MALHAM, Saudi Arabia and RIYADH, Saudi Arabia, Sept. 26, 2024 /PRNewswire/ — The 2024 Global Health Exhibition in Malham, Riyadh (21-23 October) will place a key focus on the integration of novel artificial intelligence (AI) into mainstream healthcare delivery and its power to transform the patient journey from diagnostics to outcomes, the event’s organizers announced today.

As part of the Exhibition’s Digital Health Forum, one of four parallel event tracks, world-leading experts on applying AI technology will discuss the evolution of disease and illness detection spearheaded by radiology services and showcase new AI models set to become fully integrated into diagnostic practice, both in-person and remotely.

“We are in a transformative era in radiology, where artificial intelligence and now Gen AI is redefining the entire patient experience, from enhancing diagnostic accuracy to improving safety. This paradigm shift in healthcare allows for personalised and more precise treatment options,” said Global Health Exhibition panellist Dr. Maha Gmira, Chief Technology Officer of SolutionAI.

“Through advanced deep learning algorithms, AI has shown a remarkable capacity for detecting intricate patterns in complex diseases, leading to more quantitative, data-driven diagnostic approaches. The Global Health Exhibition is an ideal platform to explore how these innovations can be harnessed in healthcare delivery, pushing the boundaries of what is possible in medical diagnostics and patient care with respect to the ethics and regulations of AI in Healthcare.”

AI is also showing significant potential in reframing clinical decision support systems to enhance decision-making processes for multidisciplinary patient care teams, as well as showing an increasing aptitude for medicines discovery, molecule screening and drug development, bringing increasing degrees of automation that significantly reduces the time required to bring a novel medicine from molecule to market. Global Health Exhibition attendees will have the opportunity to attend over forty-five sessions, panel discussions and case study presentations as part of the Digital Health Forum over the course of the event, each looking at different elements of data, intelligence and AI integration into healthcare systems.

“There is no better place in the world in 2024 for health professionals and stakeholders keen to understand the ongoing AI revolution in healthcare than Global Health Exhibition,” said Rachel Sturgess, Group Director, Tahaluf, the event’s organizer.

“AI has a multitude of applications across all areas of healthcare and this year’s exhibition will cover many of them, from its use in genomics, personalized medicine, value-based healthcare and most importantly improving patient outcomes. Attendees will also meet and interact with dynamic, innovative health businesses focused on AI and data intelligence including the winners of the Exhibition’s 2023 startup competition Cerebra AI, GE Healthcare who are expanding into the region, and global health giant Philips.”

“Bringing such a sizeable group of expert presenters in this field together is a unique privilege and offers attendees the definitive word on AI’s state of play and transformative power.”

Free registration for Global Health Exhibition is now open at www.globalhealthsaudi.com. Attendees will benefit from one of the most comprehensive and wide-ranging healthcare agendas in the world today which features world leaders in medicine and healthcare delivery from multiple international locations.

View original content:https://www.prnewswire.com/news-releases/global-health-exhibition-to-showcase-unique-advances-in-ai-enabled-diagnostics-and-patient-care-302259884.html

SOURCE Global Health Exhibition

Technology

Hexagon Interim Report 1 January – 31 March 2026

Published

59 minutes ago

April 23, 2026

STOCKHOLM, April 23, 2026 /PRNewswire/ —

First quarter 2026

Continuing operations

Operating net sales of 963.8 (961.5) resulting in organic growth of 8%Net sales including acquired deferred revenue amounted to 963.6 MEUR (961.5)Adjusted gross earnings of 606.3 (619.1) resulting in a 62.9% (64.4) gross marginAdjusted operating earnings (EBIT1) of 251.3 MEUR (248.7) resulting in a 26.1% (25.9) EBIT1 marginAdjusted earnings per share of 6.7 Euro cent (6.5)Earnings per share of 58.4 Euro cent (5.0)Cash conversion of 77% (60)Recurring revenue of 289.9 MEUR (308.0), 6% organic growthOctave reported operating net sales of 327.2 MEUR (361.3) and adjusted operating margin of 25.2% (26.6)Adjusted earnings per share including discontinued operations of 9.1 (9.4)Earnings per share including discontinued operations of 59.9 Euro cent (7.0)

For further information, please contact:
Tom Hull, Head of Investor Relations, +44 (0) 7442 678 437, ir@hexagon.com
Anton Heikenström, Investor Relations Manager, +46 8 601 26 26, ir@hexagon.com

This is information that Hexagon AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CET on 23 April 2026.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/hexagon/r/hexagon-interim-report-1-january—31-march-2026,c4338783

The following files are available for download:

https://mb.cision.com/Main/387/4338783/4053482.pdf

Hexagon Interim Report Q1 2026

View original content:https://www.prnewswire.com/news-releases/hexagon-interim-report-1-january—31-march-2026-302751432.html

SOURCE Hexagon

Technology

Dragonpass Empowers Financial Institutions with End-to-End Loyalty Solutions at Money20/20 Asia

Published

59 minutes ago

April 23, 2026

BANGKOK, April 23, 2026 /PRNewswire/ — Dragonpass, a leading global travel and lifestyle platform, participated in Money20/20 Asia, showcasing its customer loyalty solutions for banks, payment providers, credit card issuers, and fintech companies across APAC and globally.

As one of the most influential fintech events worldwide, Money20/20 Asia gathers decision-makers across the financial ecosystem. At the event, Dragonpass demonstrated how financial institutions can enhance customer engagement and build long-term loyalty through integrated travel and lifestyle experiences.

Established in 2005, Dragonpass has evolved from a lounge provider into a loyalty solutions partner, serving more than 800 global clients and over 40 million members worldwide.

At the core of Dragonpass is a business structure that combines global supply aggregation, a technology-enabled engagement platform, and consumer-facing lifestyle services — providing a one-stop solution across the customer lifecycle.

Leveraging data-driven insights, Dragonpass enables partners to design and optimise loyalty programs, incorporating customer segmentation and tiered incentive structures, alongside curated campaigns and entitlement configuration — driving more effective customer activation, engagement, and retention.

Its offering includes a broad portfolio of travel and lifestyle benefits such as airport lounge access, fast-track, dining, airport transfers, and lifestyle experiences. These are supported by flexible delivery models, including API integration, white-label solutions, and ready-to-deploy digital platforms, enabling seamless integration into clients’ customer journeys.

As customer expectations evolve, the industry is shifting from standardized benefits to more personalized, experience-led loyalty models. Insights from Dragonpass’s Loyalty Index show that customers increasingly value trust, rewards, simplicity, recognition, and exclusivity, with preferences varying across markets.

“Financial institutions today are looking for more effective ways to engage customers beyond traditional rewards,” said Jane Zhu, Co-founder and CEO of Dragonpass. “User engagement is at the core of loyalty, and technology — especially AI — plays a key role in enabling deeper and more relevant customer connections.”

Dragonpass works with leading global brands including Mastercard, Visa, HSBC, and Revolut, supporting them deliver differentiated value propositions and enhance customer engagement through scalable, customizable solutions.

Through its participation at Money20/20 Asia, Dragonpass aims to strengthen its presence in the APAC market and build strategic partnerships with organizations seeking to elevate their customer engagement strategies.

About Dragonpass

Dragonpass is a global travel and lifestyle platform providing premium airport and travel experiences across 140+ countries. By integrating global supply and technology, Dragonpass enables partners to deliver seamless, personalized experiences and drive customer loyalty.

Media Contact

Dragonpass PR
Email: brandmarketing@dragonpass.com
Website: www.dragonpass.com

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/dragonpass-empowers-financial-institutions-with-end-to-end-loyalty-solutions-at-money2020-asia-302751442.html

SOURCE Dragonpass

Technology

SBI Life Insurance registers New Business Premium of ₹42,551 crores for the year ended on 31st March, 2026

Published

59 minutes ago

April 23, 2026

MUMBAI, India, April 23, 2026 /PRNewswire/ — SBI Life Insurance, one of the leading life insurers in the country registered a New Business Premium of ₹42,551 crores for the year ended on 31st March, 2026 vis-a-vis ₹35,577 crores for the year ended 31st March, 2025. Single premium has increased by 28% over the year ended on 31st March, 2025.

Establishing a clear focus on protection, SBI Life’s protection new business premium stood at ₹4,622 crores for the year ended 31st March, 2026, marking a growth of 13%. Protection Individual new business premium registered a growth of 23% and stood at ₹973 crores for the year ended 31st March, 2026. Individual New Business Premium stands at ₹29,783 crores with 13% growth over the year ended on 31st March, 2025.

SBI Life’s profit after tax stands at ₹2,470 crores for the year ended 31st March, 2026 with a growth of 2% over the year ended on 31st March, 2025.

The company’s solvency ratio continues to remain robust at 1.90 as on 31st March, 2026 as against the regulatory requirement of 1.50.

SBI Life’s AUM also continued to grow at 9% to ₹4,87,163 crores as on 31st March, 2026 from ₹4,48,039 crores as on 31st March, 2025, with the debt-equity mix of 62:38. 94% of the debt investments are in AAA and Sovereign instruments.

The company has a diversified distribution network of 3,58,506 trained insurance professionals and wide presence with 1,230 offices across the country, comprising of strong bancassurance channel, agency channel and others comprising of corporate agents, brokers, Point of Sale Persons (POS), insurance marketing firms, web aggregators and direct business.

Performance for the year ended March 31, 2026

Private Market leadership in Individual New Business Premium and Individual Rated Premium with market share of 25.5% & 22.9% respectively.Annualized Premium Equivalent (APE) stands at ₹ 24,266 crores with growth of 13%Individual New Business Sum Assured stands at ₹ 4,46,337 crores with 61% growthImprovement in 13M & 49M persistency by 53 bps & 107 bps respectivelyValue of New Business (VoNB) stands at ₹ 6,667 crores with growth of 12%VoNB Margin stands at 27.5%Indian Embedded value (IEV) stands at ₹ 80,791 crores with 15% growthProfit After Tax (PAT) stands at ₹ 2,470 crores with 2% growthOperating Return on Embedded Value stands at 19.7% Assets under Management stands at ₹ 4,87,163 crores with 9% growthRobust Solvency ratio of 1.90

Logo: https://mma.prnewswire.com/media/2672544/SBI_Life_25_Years_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/sbi-life-insurance-registers-new-business-premium-of-42-551-crores-for-the-year-ended-on-31st-march-2026–302751447.html